JVMTX | PMCKX | JVMTX / PMCKX | |
Total Expense Ratio | 1.00 | 0.88 | 114% |
Annual Report Gross Expense Ratio | 1.11 | 0.88 | 126% |
Fund Existence | 12 years | 10 years | - |
Gain YTD | 3.456 | -0.853 | -405% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 21.8B | 677M | 3,220% |
Annual Yield % from dividends | 0.71 | 1.83 | 39% |
Returns for 1 year | -4.36 | -2.36 | 185% |
Returns for 3 years | 12.71 | 2.75 | 463% |
Returns for 5 years | 61.31 | 38.26 | 160% |
Returns for 10 years | 35.64 | -2.15 | -1,655% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XTJA | 27.94 | -0.37 | -1.29% |
Innovator US Equity Acclrtd Pls ETF Jan | |||
USSE | 30.82 | -0.60 | -1.91% |
Segall Bryant & Hamill Select Equity ETF | |||
CHI | 10.20 | -0.21 | -2.02% |
Calamos Convertible Opportunities and Income Fund | |||
EPRF | 17.32 | -0.36 | -2.04% |
Innovator S&P Investment Grade Prfrd ETF | |||
IBB | 121.69 | -2.98 | -2.39% |
iShares Biotechnology ETF |